Tonix Pharmaceuticals Holding (TNXP) Market Capitalization (2014 - 2026)

Tonix Pharmaceuticals Holding has reported Market Capitalization for 13 years, with the latest figure at $214.3 million in Q2 2026.

• On a quarterly basis, Market Capitalization fell 21.08% year-over-year to $214.3 million in Q2 2026; TTM through Jun 2026 was $214.3 million, a 21.08% decrease from a year earlier, with the FY2025 full-year figure at $132.9 million, up 447.12% from the prior year.
• Market Capitalization was $214.3 million for Q2 2026 at Tonix Pharmaceuticals Holding, up from $195.3 million in the prior quarter.
• The five-year high for Market Capitalization was $271.5 million in Q2 2025, with the low at $2.9 million in Q2 2024.
• Average Market Capitalization over 5 years is $83.6 million, with a median of $29.8 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2025: Market Capitalization tumbled 98.92% in 2022, then jumped 9394.96% in 2025.
• Over 5 years, Market Capitalization stood at $13.9 million in 2022, then slumped by 51.1% to $6.8 million in 2023, then soared by 256.5% to $24.3 million in 2024, then jumped by 447.12% to $132.9 million in 2025, then jumped by 61.17% to $214.3 million in 2026.
• The last three Market Capitalization figures came in at $214.3 million (Q2 2026), $195.3 million (Q1 2026), and $132.9 million (Q4 2025), per Business Quant data.